Publications

Men's disadvantages in TB burden and care are an issue for everyone.

HORTON, K;

2023

(2023).

Beyond latent and active tuberculosis: a scoping review of conceptual frameworks.

Zaidi, SM A; Coussens, AK; Seddon, JA; Kredo, T; Warner, D; HOUBEN, RM G J; Esmail, H;

2023

eClinicalMedicine, (2023).66, 10.1016/j.eclinm.2023.102332.

Can we find the missing men in clinics? Clinic attendance by sex and HIV status in rural South Africa.

Randera-Rees, S; Clarence Safari, W; Gareta, D; Herbst, K; BAISLEY, K; GRANT, AD;

2023

Wellcome open research, (2023).6, 10.12688/wellcomeopenres.16702.2.

T cell receptor repertoires associated with control and disease progression following Mycobacterium tuberculosis infection.

Musvosvi, M; Huang, H; Wang, C; Xia, Q; Rozot, V; Krishnan, A; Acs, P; Cheruku, A; Obermoser, G; Leslie, A; Behar, SM; Hanekom, WA; Bilek, N; Fisher, M; Kaufmann, SH E; Walzl, G; Hatherill, M; Davis, MM; Scriba, TJ; Adolescent Cohort Study team,; GC6-74 Consortium,;

2023

Nature medicine, (2023).29 1 10.1038/s41591-022-02110-9.

Quantifying the new natural history.

HORTON, K;

2023

(2023).

Treatment for radiographically active, sputum culture-negative pulmonary tuberculosis: A systematic review and meta-analysis.

Gray, AT; Macpherson, L; Carlin, F; Sossen, B; RICHARDS, AS; Kik, SV; HOUBEN, RM G J; MacPherson, P; Quartagno, M; Rogozińska, E; Esmail, H;

2023

PloS one, (2023).18 11 10.1371/journal.pone.0293535.

Diagnosis of childhood febrile illness using a multi-class blood RNA molecular signature.

Habgood-Coote, D; Wilson, C; Shimizu, C; Barendregt, AM; Philipsen, R; Galassini, R; Calle, IR; Workman, L; Agyeman, PK A; Ferwerda, G; Anderson, ST; Van den Berg, JM; Emonts, M; Carrol, ED; Fink, CG; De Groot, R; HIBBERD, ML; Kanegaye, J; Nicol, MP; Paulus, S; Pollard, AJ; Salas, A; SECKA, F; Schlapbach, LJ; Tremoulet, AH; ... Kaforou, M.

2023

Med (New York, N.Y.), (2023).4 9 10.1016/j.medj.2023.06.007.

Measuring indirect transmission-reducing effects in tuberculosis vaccine efficacy trials: why and how?.

Nelson, KN; Churchyard, G; Cobelens, F; Hanekom, WA; Hill, PC; Lopman, B; Mave, V; Rangaka, MX; Vekemans, J; WHITE, RG; Wong, EB; Martinez, L; García-Basteiro, AL;

2023

The Lancet. Microbe, (2023).4 8 10.1016/s2666-5247(23)00112-x.

Ending TB means responding to socially produced vulnerabilities of all genders.

Ringwald, B; Mwiine, AA; Chikovore, J; Makanda, G; Amoah-Larbi, J; Millington, KA; HORTON, KC;

2023

BMJ Global Health, (2023).8 12 10.1136/bmjgh-2023-014151.

Emergence of bedaquiline-resistant tuberculosis and of multidrug-resistant and extensively drug-resistant Mycobacterium tuberculosis strains with rpoB Ile491Phe mutation not detected by Xpert MTB/RIF in Mozambique: a retrospective observational study.

Barilar, I; Fernando, T; Utpatel, C; Abujate, C; Madeira, CM; José, B; Mutaquiha, C; KRANZER, K; Niemann, T; Ismael, N; De Araujo, L; Wirth, T; Niemann, S; Viegas, S;

2023

The Lancet. Infectious diseases, (2023).24 3 10.1016/s1473-3099(23)00498-x.